Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RVNC

Revance Therapeutics (RVNC)

Revance Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RVNC
DateTimeSourceHeadlineSymbolCompany
06/01/20208:30AMBusiness WireRevance and Mylan to Advance Development Program for Biosimilar to BOTOX®NASDAQ:RVNCRevance Therapeutics Inc
05/21/20206:10AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RVNCRevance Therapeutics Inc
05/21/20206:08AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:RVNCRevance Therapeutics Inc
05/20/20206:03AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RVNCRevance Therapeutics Inc
05/19/20205:14PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RVNCRevance Therapeutics Inc
05/19/20205:13PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RVNCRevance Therapeutics Inc
05/19/20204:26PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RVNCRevance Therapeutics Inc
05/19/20204:23PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RVNCRevance Therapeutics Inc
05/19/20204:20PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RVNCRevance Therapeutics Inc
05/19/20204:18PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RVNCRevance Therapeutics Inc
05/19/20208:23AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RVNCRevance Therapeutics Inc
05/19/20208:18AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RVNCRevance Therapeutics Inc
05/19/20208:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVNCRevance Therapeutics Inc
05/19/20208:01AMBusiness WireRevance Announces Agreement to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic PracticesNASDAQ:RVNCRevance Therapeutics Inc
05/15/20206:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
05/15/20206:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
05/15/20206:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
05/15/20206:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
05/15/20206:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
05/15/20206:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
05/15/20206:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
05/15/20204:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVNCRevance Therapeutics Inc
05/07/20205:26PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RVNCRevance Therapeutics Inc
05/07/20204:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVNCRevance Therapeutics Inc
05/07/20204:05PMBusiness WireRevance Reports First Quarter 2020 Financial Results, Provides Corporate UpdateNASDAQ:RVNCRevance Therapeutics Inc
05/01/20208:30AMBusiness WireRevance and Mylan Biosimilar to BOTOX® Program Decision to Extend Beyond April 30, 2020NASDAQ:RVNCRevance Therapeutics Inc
04/30/20204:05PMBusiness WireRevance to Release First Quarter 2020 Financial Results on Thursday, May 7, 2020NASDAQ:RVNCRevance Therapeutics Inc
04/21/20208:05AMGlobeNewswire Inc.Outlook Therapeutics Bolsters Clinical and Commercial Expertise with Two Key Appointments to Board of DirectorsNASDAQ:RVNCRevance Therapeutics Inc
04/17/20207:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVNCRevance Therapeutics Inc
04/07/20204:05PMBusiness WireRevance to Participate in the 19th Annual Needham Virtual Healthcare ConferenceNASDAQ:RVNCRevance Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RVNC

Your Recent History

Delayed Upgrade Clock